190 related articles for article (PubMed ID: 36660663)
1. MiR-202-3p inhibits the proliferation and metastasis of lung adenocarcinoma cells by targeting RRM2.
Cao X; Xue F; Chen H; Shen L; Yuan X; Yu Y; Zong Y; Zhong L; Huang F
Ann Transl Med; 2022 Dec; 10(24):1374. PubMed ID: 36660663
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway.
Xu H; Li B
Bioengineered; 2022 May; 13(5):12876-12887. PubMed ID: 35609318
[TBL] [Abstract][Full Text] [Related]
3. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.
Liu Y; Zhang Y; Li Q; Xu R; Huang N
Thorac Cancer; 2022 Jul; 13(13):1974-1985. PubMed ID: 35599447
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance and mechanism of microRNA-22-3p targeting TP53 in lung adenocarcinoma.
Lin R; Li GS; Gan XY; Peng JX; Feng Y; Wang LT; Zhang CY; Huang KY; Huang SH; Yang L; Kong JL; Zhou HF; Chen G; Huang WY
Technol Health Care; 2023; 31(5):1691-1707. PubMed ID: 36970920
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B
Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974
[TBL] [Abstract][Full Text] [Related]
7. Oxymatrine induces anti-tumor response in cervical cancer by modulating circ_0008460/miR-197-3p/ribonucleotide reductase subunit M2 (RRM2).
Li S; Zhang H; Jiao Y; Song X; Wei L; Liu X
Bioengineered; 2022 May; 13(5):12912-12926. PubMed ID: 35609310
[TBL] [Abstract][Full Text] [Related]
8. Novel Biomarker
Yang T; Si Q; Liu M; DU R; Ji L; Zhang X; Su J; Sun H; Wang L; Zhao C; Liu J; Ouyang S; Dai L
Anticancer Res; 2023 Nov; 43(11):4923-4935. PubMed ID: 37909971
[TBL] [Abstract][Full Text] [Related]
9. Prognosis Value of microRNA-3677-3p in Lung Adenocarcinoma and Its Regulatory Effect on Tumor Progression.
Zhao J; Yu H; Han T; Zhu X
Cancer Manag Res; 2021; 13():9261-9270. PubMed ID: 34955656
[TBL] [Abstract][Full Text] [Related]
10. MiR-490-3p Inhibits the Malignant Progression of Lung Adenocarcinoma.
Li Z; Jiang D; Yang S
Cancer Manag Res; 2020; 12():10975-10984. PubMed ID: 33154676
[TBL] [Abstract][Full Text] [Related]
11. Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression.
Wang Y; Wo Y; Lu T; Sun X; Liu A; Dong Y; Du W; Su W; Huang Z; Jiao W
Transl Lung Cancer Res; 2021 Jan; 10(1):57-70. PubMed ID: 33569293
[TBL] [Abstract][Full Text] [Related]
12. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of hsa-miR-30b-3p Inhibits the Oncogenicity of Lung Adenocarcinoma by Targeting the
Li N; Li R; Song B; Ge H; Qu Y
J Oncol; 2022; 2022():6883140. PubMed ID: 35646115
[TBL] [Abstract][Full Text] [Related]
14. E2F8 exerts cancer-promoting effects by transcriptionally activating RRM2 and E2F8 knockdown synergizes with WEE1 inhibition in suppressing lung adenocarcinoma.
Liu K; Wang L; Lou Z; Guo L; Xu Y; Qi H; Fang Z; Mei L; Chen X; Zhang X; Shao J; Xiang X
Biochem Pharmacol; 2023 Dec; 218():115854. PubMed ID: 37863324
[TBL] [Abstract][Full Text] [Related]
15. miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.
Hu C; Wu J; Wang L; Liu X; Da B; Liu Y; Huang L; Chen Q; Tong Y; Jiang Z
Pathol Res Pract; 2021 Jul; 223():153459. PubMed ID: 33971546
[TBL] [Abstract][Full Text] [Related]
16. MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A1.
Sun Y; Liu Z; Huang L; Shang Y
J Chemother; 2021 Oct; 33(6):409-419. PubMed ID: 33845716
[TBL] [Abstract][Full Text] [Related]
17. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
Wang Y; Mei X; Song W; Wang C; Qiu X
BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
[TBL] [Abstract][Full Text] [Related]
19. RRM2 Regulated By LINC00667/miR-143-3p Signal Is Responsible For Non-Small Cell Lung Cancer Cell Progression.
Yang Y; Li S; Cao J; Li Y; Hu H; Wu Z
Onco Targets Ther; 2019; 12():9927-9939. PubMed ID: 31819489
[TBL] [Abstract][Full Text] [Related]
20. Cancer-derived exosomal miR-197-3p confers angiogenesis via targeting TIMP2/3 in lung adenocarcinoma metastasis.
Chang RM; Fu Y; Zeng J; Zhu XY; Gao Y
Cell Death Dis; 2022 Dec; 13(12):1032. PubMed ID: 36494333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
